Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Rob 803
2. 872178-65-9
3. Rabeximod [inn]
4. Rob-803
5. J4d3k58w3z
6. Rabeximodum
7. Rabeximodum [inn]
8. Unii-j4d3k58w3z
9. Rob803
10. Gtpl9856
11. Schembl16053849
12. Dtxsid701007428
13. Db05772
14. Sb18674
15. Q27281185
16. 2-(9-chloro-2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-n-[2-(dimethylamino)ethyl]acetamide
17. 2-(9-chloro-2,3-dimethyl-6h-indolo[2,3-b]quinoxalin-6-yl)-n-[2-(dimethylamino)ethyl]ethanimidic Acid
18. 6h-indolo(2,3-b)quinoxaline-6-acetamide, 9-chloro-n-(2-(dimethylamino)ethyl)-2,3-dimethyl-
Molecular Weight | 409.9 g/mol |
---|---|
Molecular Formula | C22H24ClN5O |
XLogP3 | 3.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 409.1669381 g/mol |
Monoisotopic Mass | 409.1669381 g/mol |
Topological Polar Surface Area | 63 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 590 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in rheumatoid arthritis.
Rob 803 is an immunomodulator.
ABOUT THIS PAGE
95
PharmaCompass offers a list of Rabeximod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rabeximod manufacturer or Rabeximod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rabeximod manufacturer or Rabeximod supplier.
PharmaCompass also assists you with knowing the Rabeximod API Price utilized in the formulation of products. Rabeximod API Price is not always fixed or binding as the Rabeximod Price is obtained through a variety of data sources. The Rabeximod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rabeximod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rabeximod, including repackagers and relabelers. The FDA regulates Rabeximod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rabeximod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rabeximod supplier is an individual or a company that provides Rabeximod active pharmaceutical ingredient (API) or Rabeximod finished formulations upon request. The Rabeximod suppliers may include Rabeximod API manufacturers, exporters, distributors and traders.
Rabeximod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rabeximod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rabeximod GMP manufacturer or Rabeximod GMP API supplier for your needs.
A Rabeximod CoA (Certificate of Analysis) is a formal document that attests to Rabeximod's compliance with Rabeximod specifications and serves as a tool for batch-level quality control.
Rabeximod CoA mostly includes findings from lab analyses of a specific batch. For each Rabeximod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rabeximod may be tested according to a variety of international standards, such as European Pharmacopoeia (Rabeximod EP), Rabeximod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rabeximod USP).